Literature DB >> 8117756

Identification of the phenotype in psychiatric genetics.

M T Tsuang1, S V Faraone, M J Lyons.   

Abstract

Statistical procedures and molecular genetic techniques have attained a fine degree of resolution. Their ability to find disease genes has revolutionized medicine and raised hopes for breakthroughs in psychiatry. However, such breakthroughs may require an equally discriminating nosology. A psychiatric genetic nosology seeks to classify patients into categories that correspond to distinct genetic entities by addressing the problem of diagnostic accuracy: the degree to which a diagnosis correctly classifies people with and without a putative genetic illness. We review methods that deal with misclassification in genetic studies. These are clinical and epidemiological approaches that deal directly with how to define the observable manifestation of a putative genotype. We discuss two groups of methods: those that use known phenotypes and those that design new phenotypes.

Entities:  

Mesh:

Year:  1993        PMID: 8117756     DOI: 10.1007/bf02190719

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  86 in total

1.  On dependent repeated screening tests.

Authors:  T S Lau
Journal:  Biometrics       Date:  1991-03       Impact factor: 2.571

Review 2.  Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders.

Authors:  J Biederman; J Newcorn; S Sprich
Journal:  Am J Psychiatry       Date:  1991-05       Impact factor: 18.112

3.  Using signal detection methodology to revise DSM-III-R: re-analysis of the DSM-III-R national field trials for autistic disorder.

Authors:  B Siegel; J Vukicevic; R L Spitzer
Journal:  J Psychiatr Res       Date:  1990       Impact factor: 4.791

4.  Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene.

Authors:  M C Chartier-Harlin; F Crawford; H Houlden; A Warren; D Hughes; L Fidani; A Goate; M Rossor; P Roques; J Hardy
Journal:  Nature       Date:  1991-10-31       Impact factor: 49.962

5.  Localization of a susceptibility locus for schizophrenia on chromosome 5.

Authors:  R Sherrington; J Brynjolfsson; H Petursson; M Potter; K Dudleston; B Barraclough; J Wasmuth; M Dobbs; H Gurling
Journal:  Nature       Date:  1988-11-10       Impact factor: 49.962

6.  Sporadic vs familial classification given etiologic heterogeneity: I. Sensitivity, specificity, and positive and negative predictive value.

Authors:  K S Kendler
Journal:  Genet Epidemiol       Date:  1987       Impact factor: 2.135

Review 7.  Methodological issues facing the interpretation of high-risk studies: biological heterogeneity.

Authors:  D L Garver
Journal:  Schizophr Bull       Date:  1987       Impact factor: 9.306

8.  The DSM-III-R field trial of disruptive behavior disorders.

Authors:  R L Spitzer; M Davies; R A Barkley
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1990-09       Impact factor: 8.829

9.  Evidence of familial association between attention deficit disorder and major affective disorders.

Authors:  J Biederman; S V Faraone; K Keenan; M T Tsuang
Journal:  Arch Gen Psychiatry       Date:  1991-07

10.  Familial and sporadic schizophrenia: a symptomatic, prognostic, and EEG comparison.

Authors:  K S Kendler; P Hays
Journal:  Am J Psychiatry       Date:  1982-12       Impact factor: 18.112

View more
  32 in total

1.  Psychopharmacogenetics and psychiatric genetics: similar methodological challenges.

Authors:  M Maziade; M A Roy; C Mérette; L Bissonnette; R Quirion; R Palmour
Journal:  J Psychiatry Neurosci       Date:  1999-05       Impact factor: 6.186

Review 2.  Neuroeconomics: a bridge for translational research.

Authors:  Carla Sharp; John Monterosso; P Read Montague
Journal:  Biol Psychiatry       Date:  2012-07-15       Impact factor: 13.382

Review 3.  Genetics in child and adolescent psychiatry: methodological advances and conceptual issues.

Authors:  Sarah Hohmann; Nicoletta Adamo; Benjamin B Lahey; Stephen V Faraone; Tobias Banaschewski
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-04-08       Impact factor: 4.785

4.  Bug-eyed and breathless: emerging crises involving values.

Authors:  John Z Sadler
Journal:  World Psychiatry       Date:  2005-06       Impact factor: 49.548

Review 5.  Rapid eye movement (REM) sleep: an endophenotype for depression.

Authors:  Sieglinde Modell; Christoph J Lauer
Journal:  Curr Psychiatry Rep       Date:  2007-12       Impact factor: 5.285

Review 6.  Recent Genetics and Epigenetics Approaches to PTSD.

Authors:  Nikolaos P Daskalakis; Chuda M Rijal; Christopher King; Laura M Huckins; Kerry J Ressler
Journal:  Curr Psychiatry Rep       Date:  2018-04-05       Impact factor: 5.285

Review 7.  Imaging genetic liability to schizophrenia: systematic review of FMRI studies of patients' nonpsychotic relatives.

Authors:  Angus W MacDonald; Heidi W Thermenos; Deanna M Barch; Larry J Seidman
Journal:  Schizophr Bull       Date:  2008-06-12       Impact factor: 9.306

8.  Advances in endophenotyping schizophrenia.

Authors:  David L Braff; Tiffany A Greenwood; Neal R Swerdlow; Gregory A Light; Nicholas J Schork
Journal:  World Psychiatry       Date:  2008-02       Impact factor: 49.548

9.  Familial transmission of derived phenotypes for molecular genetic studies of substance use disorders.

Authors:  Stephen V Faraone; Joel J Adamson; Timothy E Wilens; Michael C Monuteaux; Joseph Biederman
Journal:  Drug Alcohol Depend       Date:  2007-09-04       Impact factor: 4.492

10.  Decreased white matter FA values in the left inferior frontal gyrus is a possible intermediate phenotype of schizophrenia: evidences from a novel group strategy.

Authors:  Jianjun Ou; Hailong Lyu; Maorong Hu; Jun Li; Wenbin Guo; Xiaofeng Guo; Lihua Li; Junjie Zheng; Qinling Wei; Feng Liu; Zhong He; Juan Wang; Fang Liu; Renrong Wu; Jindong Chen; Lehua Li; Bin Hu; Huafu Chen; Jingping Zhao
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-12-09       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.